- Akzo Nobel NVSee all
The company and law firm names shown above are generated automatically based on the text of the article. We are improving this feature as we continue to test and develop in beta. We welcome feedback, which you can provide using the feedback tab on the right of the page.
AMSTERDAM, Sept 3 (Reuters) - Nouryon BV, the former chemicals arm of AkzoNobel, said on Friday it had filed an application with the U.S. Securities and Exchange Commission (SEC) to seek an initial public offering (IPO) of shares.
Akzo sold Nouryon to The Carlyle Group in 2018 in a deal then worth 10.1 billion euros ($12 billion).
Nouryon had adjusted earnings before interest, taxes, depreciation and amortisation (EBITDA) of $970 million in 2020 on sales of $4.2 billion, a company fact sheet published on its website said.
Nouryon said on its website it had submitted a draft registration statement to the SEC and the IPO was expected to "commence after the SEC completes its review process."
Company Communications Officer Vivi Hollertt said she could not comment beyond the press statement and would not say exchange the company was considering for its listing.
"The number of shares to be offered and the price range for the proposed offering have not yet been determined," the statement said. "Nouryon expects to use the proceeds of the offering for general corporate purposes, which may include the repayment of indebtedness."
($1 = 0.8424 euros)